Next big COVID-19 treatment may be manufactured antibodies

1 Comment
By Deena Beasley

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2020.

©2020 GPlusMedia Inc.

1 Comment
Login to comment

Monoclonal antibodies are a very effective way to neutralize viruses but it is difficult to see them used as a generalized treatment. They are expensive and complicated to produce, they have some risks and applied too late has the possibility of making them not only ineffective but even dangerous.

It is more likely they will be used on very specific patients, infected and with high risk of complications but not yet very sick, or as a preventive measure for people without a proper immunity and with a risk of exposure (for example cancer patients that require treatment in a hospital).

2 ( +2 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites